Stanley-Laman Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $297K | Sell |
668
-334
| -33% | -$149K | 0.04% | 236 |
|
|
2025
Q1 | $486K | Buy |
+1,002
| New | +$486K | 0.07% | 198 |
|
|
2024
Q4 | – | Sell |
-436
| Closed | -$203K | – | 298 |
|
|
2024
Q3 | $203K | Buy |
+436
| New | +$203K | 0.03% | 283 |
|
|
2022
Q2 | – | Sell |
-1,323
| Closed | -$345K | – | 310 |
|
|
2022
Q1 | $345K | Buy |
+1,323
| New | +$345K | 0.05% | 215 |
|
|
2021
Q1 | – | Sell |
-2,168
| Closed | -$512K | – | 267 |
|
|
2020
Q4 | $512K | Buy |
2,168
+964
| +80% | +$228K | 0.09% | 209 |
|
|
2020
Q3 | $328K | Buy |
+1,204
| New | +$328K | 0.07% | 201 |
|
|
2019
Q1 | – | Sell |
-1,498
| Closed | -$248K | – | 272 |
|
|
2018
Q4 | $248K | Buy |
+1,498
| New | +$248K | 0.07% | 231 |
|